Report : North America Autotransfusion Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Product and Accessories), Application (Cardiac Surgeries, Orthopaedic Surgeries, Organ Transplantation, Trauma Procedures, and Others), and End User (Hospitals, Specialty Clinics, and Ambulatory Surgery Centers) and Country
According to The Insight Partners market research study of “North America Autotransfusion Devices Forecast to 2027 - COVID-19 Impact and Global Analysis by Type, Application and End-User,” the North America Autotransfusion Devices is projected to reach US$ 426.31 million by 2027 from US$ 305.15 million in 2019. The market is estimated to grow at CAGR of 4.4% from 2020 to 2027. The report highlights trends prevailing in the North America Autotransfusion Devices market and the factors driving market along with those that act as hindrances.
Based on type, the North America Autotransfusion Devices market is further segmented into products and accessories. The product segment held the largest share of the market in 2019. However, the Accessories segment is estimated to register the highest CAGR in the market during the forecast period. The autotransfusion products comprises a system that operates in combination with various components, such as wash kits, vacuum pump, transfer bags, and others. Autotransfusion products are easy to use, and a few are fully automated. For example, the autoLog autotransfusion system by Medtronic is fully automated. It operates in a two-stage filling cycle—the initial stage and final stage. This two-stage processing helps in the smooth transition of blood flow during the process. The system is fitted with a level sensor that controls and monitors the red cell pack level. The product segment is further categorized into intraoperative autotransfusion system, postoperative autotransfusion system, dual mode autotransfusion system.
North America Autotransfusion Devices market is expected to grow owing to factors such as growth include involvement of rare blood groups, rising number of transplant procedures and rising prevalence of chronic diseases. Whereas, the market is likely to have negative impact due to the, risks associated with autotransfusion.
The report segments in North America Autotransfusion Devices market as follows: